# Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis

> **NCT02166021** · PHASE2 · COMPLETED · sponsor: **Dimitrios Karussis** · enrollment: 48 (actual)

## Conditions studied

- Multiple Sclerosis (MS)

## Interventions

- **BIOLOGICAL:** Mesenchymal stem cells

## Key facts

- **NCT ID:** NCT02166021
- **Lead sponsor:** Dimitrios Karussis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-29
- **Primary completion:** 2018-06-15
- **Final completion:** 2018-12-24
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02166021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02166021, "Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02166021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*